Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $44.12-$63.45 |
Market Cap | $4.8B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $13.3M |
Revenue Growth (YoY) | 1,041.4% |
Gross Profit (12 Mos) | -$461.8M |
Diluted EPS | -$4.74 |
News
See moreYahoo Finance • 17 hours ago
Vertex Slumps On Light Pain Drug Sales, But A Key Kidney Catalyst Lies Ahead
Yahoo Finance • 2 days ago
Vertex Yo-Yos On Mixed Third-Quarter Report, Light Guidance Hike
Yahoo Finance • 2 days ago
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
Yahoo Finance • 16 days ago
Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |